Kowald Axel, Kemeth Felix P, Kirkwood Tom B L
UK National Innovation Centre for Ageing, The Catalyst, 3 Science Square, Newcastle University, Newcastle upon Tyne NE4 5TG, UK.
Rostock University Medical Center, Institute for Biostatistics and Informatics in Medicine and Aging Research (IBIMA), 18057 Rostock, Germany.
PNAS Nexus. 2022 Sep 16;1(4):pgac192. doi: 10.1093/pnasnexus/pgac192. eCollection 2022 Sep.
Mitochondria are cellular organelles of crucial relevance for the survival of metazoan organisms. Damage to the mitochondrial DNA can give rise to a variety of mitochondrial diseases and is thought also to be involved in the aging process. The fate of mtDNA mutants is controlled by their synthesis as well as degradation and mathematical models can help to better understand this complex interplay. We present here a model that combines a replicative advantage for mtDNA mutants with selective degradation enabled by mitochondrial fission and fusion processes. The model not only shows that the cell has efficient means to deal with (many) types of mutants but, surprisingly, also predicts that under certain conditions a stable co-existence of mutant and wild-type mtDNAs is possible. We discuss how this new finding might explain how mitochondria can be at the heart of processes with such different phenotypes as mitochondrial diseases and aging.
线粒体是后生动物生存至关重要的细胞器。线粒体DNA的损伤会引发多种线粒体疾病,并且被认为也与衰老过程有关。线粒体DNA突变体的命运受其合成以及降解的控制,数学模型有助于更好地理解这种复杂的相互作用。我们在此展示一个模型,该模型将线粒体DNA突变体的复制优势与线粒体分裂和融合过程所促成的选择性降解结合起来。该模型不仅表明细胞有有效的方式来应对多种类型的突变体,而且令人惊讶的是,还预测在某些条件下突变型和野生型线粒体DNA可能稳定共存。我们讨论了这一新发现如何解释线粒体为何会处于线粒体疾病和衰老等具有如此不同表型的过程的核心位置。